The relationship between resilience and rational drug use in liver transplant patients

Objective: This study was conducted as relational descriptive to determine the relationship between resilience and rational drug use in liver transplant patients. Materials and Methods: This study was conducted between January 2020 and May 2021 at a Liver Transplant Institute of Turgut Özal Medical Center. The sample of the study consisted of 105 patients who had liver transplant. In data collection, Socio-demographic Data Form, Brief Resilience Scale and Rational Drug Use Scale were used. Institutional and ethics committee permissions were obtained for the study. Data were collected by face-to-face interview method. Results: The average score obtained from the Rational Drug Use Scale was found as 80.0 ± 9.53 (high) and Brief Resilience Scale as 18.19 ± 5.69 (normal level). In the psychological resilience scale; The scores of patients who smoke and those who received information about drug use from a doctor were found to be statistically significantly higher (p<0.05). In the Rational Drug Use scale; The scores of the patients who were literate, had private health insurance and were 13-18 months after the transplant were found to be statistically significantly higher (p<0.05). There was no statistically significant relationship between the Rational Drug Use Scale and the Brief Resilience Scale (p>0.05). Conclusion: In this study, the level of Rational Drug Use was found to be high and Resilience level was found to be low. There was no statistically significant relationship between Rational Drug Use Scale and the Brief Resilience Scale. In line with these results, it can be stated that nurses should follow whether patients who have undergone liver transplantation act in accordance with the principles of rational drug use, they should provide training on this subject in discharge education, and that they should guide patients by evaluating them in terms of resilience.